Piramal Pharma Limited (NSE:PPLPHARMA)

India flag India · Delayed Price · Currency is INR
209.05
-9.46 (-4.33%)
Feb 21, 2025, 3:29 PM IST
57.95%
Market Cap 277.15B
Revenue (ttm) 89.49B
Net Income (ttm) 389.00M
Shares Out 1.33B
EPS (ttm) 0.29
PE Ratio 712.46
Forward PE 60.34
Dividend 0.11 (0.05%)
Ex-Dividend Date n/a
Volume 16,365,100
Average Volume 9,456,070
Open 216.77
Previous Close 218.51
Day's Range 206.31 - 222.50
52-Week Range 114.35 - 307.90
Beta 0.09
RSI 44.69
Earnings Date May 9, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.